Report Highlights
-
The U.S. market for prosthetics, orthotics and cosmetic enhancement products is expected to increase from $6.8 billion in 2005 to $10.8 billion in 2010, at an AAGR (average annual growth rate) of 9.9%.
-
Cosmetic enhancement products have a much higher projected AAGR (28.2%) than either prosthetics (5.5%) or orthotics (3.6%). As a result, cosmetic enhancement products will increase their market share to 30.3% in 2010.
-
Both prostheses and orthoses are expected to lose market share, i.e., from 78.9% to 63.3% and from 8.8% to 6.4%, respectively.
-
Currently, the largest-selling products are dental crowns and bridges and hip and knee implants. Products expected to show the greatest growth by 2010 include botulinum toxin dermal fillers and dental implants.
INTRODUCTION
The prosthetics, orthotics and cosmetic enhancement products industries are entering into a period of extraordinary opportunities. This is due to a convergence of technological, demographic, cultural and economic factors. Advances in materials technology, miniaturization, electronics and operative procedures are opening up many new possibilities.
At the same time, the populations of the U.S. and other advanced countries are growing older, resulting in a continual growth in the number of people suffering from physical disabilities and other conditions that medical science increasingly is equipped to ameliorate. Many of these same individuals have enjoyed unprecedented earnings during their working lives, and look forward to financially comfortable retirement years. As a result, they will have the money to spend on prosthetics, orthotics and cosmetic enhancement products, with or without the help of health insurance.
This BCC report is both a survey of products on the marketplace and a preview of things to come. The study examines market opportunities for prosthetic and orthotics devices and cosmetic enhancement products and the technologies that make possible the more advanced products that rapidly are coming into being.
SCOPE OF STUDY
The report contains:
- Discussion of major product types and applications, both commercial and developmental
- An overview of market size and segmentation, including historical data on sales by application and product type
- Market drivers and constraints
- Detailed market projections through 2010
- Analysis of industry structure, competition and market shares
- Discussion of factors that may influence the long-term market for prosthetic and orthotics devices and cosmetic enhancement products.
METHODOLOGY AND INFORMATION SOURCES
The findings and conclusions of this report are based on information gathered from manufacturers and distributors, hospitals, doctors, and other end users. Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature, and on-line databases to produce the baseline market estimates contained in this report.
The base year for analysis and projection is 2004. With 2004 as a baseline, market projections were developed for 2005 to 2010. These projections are based on consensus among the primary contacts in combination with our understanding of the key market drivers and their impact from a historical and analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in the section on Detailed Market Projections.
All dollar projections presented in this report are in 2004 constant dollars.
ANALYST CREDENTIALS
The author of this report is Andrew McWilliams. Mr. McWilliams, a partner in the Boston-based international technology and marketing consulting firm of 43rd Parallel LLC, is the author of several other Communications Company studies of the health care and related industries, including: B-127R Microelectronic Medical Implants: Products, Technologies and Opportunities; B-207 Radiation-based Therapy and Therapeutic Imaging; B-159R Biosensors and Bioelectronics; C-140N, Trends in the Noninvasive and Minimally Invasive Medical Device Market and B-182 Medical Robotics and Computer Assisted Surgery Market. Two of Mr. McWilliams' other recent studies, GB-290 Nanotechnology: A Realistic Market Evaluation, and GB-329 Nanotechnology in Life Science Applications also cover applications of nanotechnology in the fabrication of high-performance, biocompatible materials for prostheses and other implanted medical devices.
Related Reports
Recent Reports
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials
The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.
Global Cleanroom Technology Market
The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Microelectromechanical Systems (MEMS) in Global Medical Markets
The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More